Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹21 Cr₹25 Cr₹-69 Cr₹-136 Cr₹38 Cr

What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES is ₹21 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹21 Cr
Mar2025₹25 Cr
Mar2024₹-69 Cr
Mar2023₹-136 Cr
Mar2022₹38 Cr

How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹21 Cr
-15.97
Mar2025 ₹25 Cr
Positive
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹-136 Cr
Negative
Mar2022 ₹38 Cr -

Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹29,280.9 Cr -4.8% -2.9% 45.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr 0.1% -0.6% 15.2% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr -0.6% 8.7% 53% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -0.8% -1.7% 34.7% Stock Analytics
CIPLA ₹110,794.0 Cr -0.6% -4.2% -12.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 2.7% -0.7% -12.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-4.8%

-2.9%

45.6%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses